We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,779 results
  1. The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis

    Background

    Modulators of triglyceride metabolism include lipoprotein lipase (LPL), angiopoietin-like protein 4 (ANGPTL4), and apolipoprotein C-3...

    Laura de Armas-Rillo, Juan Carlos Quevedo-Abeledo, ... Iván Ferraz-Amaro in Arthritis Research & Therapy
    Article Open access 29 April 2022
  2. Rare novel LPL mutations are associated with neonatal onset lipoprotein lipase (LPL) deficiency in two cases

    Background

    Lipoprotein lipase (LPL) deficiency is a monogenic lipid metabolism disorder biochemically characterized by hypertriglyceridemia (HTG)...

    Yun Qin Wu, Yue Yuan Hu, Gui Nan Li in BMC Pediatrics
    Article Open access 20 September 2021
  3. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review

    Apolipoprotein C1 (apoC1) is a small size apolipoprotein whose exact role is not totally clarified but which seems to modulate significantly the...

    Alexia Rouland, David Masson, ... Benjamin Bouillet in Cardiovascular Diabetology
    Article Open access 05 December 2022
  4. Is lysosomal acid lipase activity associated with the presence and severity of coronary artery disease?

    Background

    Lipid metabolism is considerably complex and there can be many critical steps in atherogenesis. The association between lysosomal acid...

    Emrullah Kızıltunç, Sabire Gökalp, ... Adnan Abacı in Herz
    Article 01 August 2023
  5. Lipoprotein Lipase Deficiency

    Objectives

    To analyse the clinical and molecular spectrum of Lipoprotein Lipase (LPL) deficiency and to highlight the effect of a cost-effective...

    Shwetha Kuthiroly, Dhanya Yesodharan, ... Sheela Nampoothiri in The Indian Journal of Pediatrics
    Article 30 May 2020
  6. Lipoprotein Lipase Deficiency: Diet is the Key!

    Kshitija Patil, Neerja Gupta in The Indian Journal of Pediatrics
    Article 12 January 2021
  7. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report

    Background

    Lipoprotein glomerulopathy (LPG) is a apolipoprotein E (ApoE)-related glomerular disease and has been associated with type III...

    Junichiro Kato, Hideo Okonogi, ... Takashi Yokoo in BMC Nephrology
    Article Open access 20 May 2024
  8. New Strategies for Lowering Low-Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention

    Purpose of Review

    The primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) relies on optimizing cardiovascular health...

    Sean Paul Gaine, Renato Quispe, ... Erin D. Michos in Current Cardiovascular Risk Reports
    Article 25 June 2022
  9. Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms

    Purpose of Review

    Lipoprotein (a) [Lp(a)] is a highly atherogenic lipoprotein species. A unique feature of Lp(a) is the strong genetic determination...

    Kévin Chemello, Dirk J. Blom, ... Valentin Blanchard in Current Atherosclerosis Reports
    Article 30 March 2022
  10. Increased high-density lipoprotein cholesterol in patients with type 2 diabetes and its correlates: a cross-sectional, matched case–control survey

    Background

    So far, high-density lipoprotein cholesterol (HDL-C) levels and mortality were shown to have a U-shaped relationship. Additionally, high...

    Fatemeh Heydarzadeh, Fatemeh Mohammadi, ... Manouchehr Nakhjavani in European Journal of Medical Research
    Article Open access 02 July 2024
  11. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus

    Background

    Previous research has linked elevated low-density lipoprotein cholesterol (LDL-C) and remnant cholesterol (RC) with diabetes mellitus (DM)....

    **angming Hu, Qunzhi Liu, ... Ji** Lin in Cardiovascular Diabetology
    Article Open access 27 June 2022
  12. A nonlinear relationship between the triglycerides to high-density lipoprotein cholesterol ratio and stroke risk: an analysis based on data from the China Health and Retirement Longitudinal Study

    Objective

    The connection between triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio and stroke risk is controversial. Our goal was...

    Shike Zhang, Changchun Cao, ... **aodan Zheng in Diabetology & Metabolic Syndrome
    Article Open access 27 April 2024
  13. High-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Risk Assessment: Exploring and Explaining the “U”-Shaped Curve

    Purpose of Review

    Review updates for the association of HDL-cholesterol with atherosclerotic cardiovascular disease (ASCVD) and discuss the approach...

    Alexander C. Razavi, Anurag Mehta, ... Arshed A. Quyyumi in Current Cardiology Reports
    Article 16 November 2023
  14. A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time

    Background

    Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g....

    Hayato Isobe, Masashi Shimoda, ... Hideaki Kaneto in BMC Endocrine Disorders
    Article Open access 09 June 2021
  15. Association of triglycerides to high-density lipoprotein cholesterol ratio with incident cardiovascular disease but not end-stage kidney disease among patients with biopsy-proven diabetic nephropathy

    Increased triglycerides (TG) and decreased high-density lipoprotein cholesterol (HDL-C) are dyslipidemias characteristic of diabetes. Here, we aimed...

    Takayuki Uemura, Masatoshi Nishimoto, ... Kazuhiko Tsuruya in Hypertension Research
    Article 07 February 2023
  16. MicroRNAs and Circular RNAs in Lipoprotein Metabolism

    Purpose of Review

    Non-coding RNAs (ncRNAs) including microRNAs (miRNAs) and circular RNAs (circRNAs) are pivotal regulators of mRNA and protein...

    Pablo Fernández-Tussy, Inmaculada Ruz-Maldonado, Carlos Fernández-Hernando in Current Atherosclerosis Reports
    Article 10 May 2021
  17. Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

    Background

    Lp-PLA2 is linked to cardiovascular diseases and poor outcomes, especially in diabetes, as it functions as a pro-inflammatory and oxidative...

    Shudong Zhang, Jiangang Wang, ... Qiu**g Chen in BMC Cardiovascular Disorders
    Article Open access 14 May 2024
  18. Long-term visit-to-visit variability in low-density lipoprotein cholesterol is associated with poor cardiovascular and kidney outcomes in patients with primary nephrotic syndrome

    Purpose

    It is unclear whether long-term variability in low-density lipoprotein cholesterol (LDL-C) is associated with clinical outcomes in patients...

    Xuan Lai, Zhao Cui, ... Ming-Hui Zhao in International Urology and Nephrology
    Article 17 January 2023
  19. The Role of High-Density Lipoprotein Cholesterol in 2022

    Purpose of the Review

    High-density lipoproteins (HDL) are responsible for the transport in plasma of a large fraction of circulating lipids, in part...

    Cesare R. Sirtori, Alberto Corsini, Massimiliano Ruscica in Current Atherosclerosis Reports
    Article Open access 10 March 2022
Did you find what you were looking for? Share feedback.